Skip to Content

Avapritinib (Ayvakit®) for Indolent Systemic Mastocytosis

Download PQI pdf 0.22MB

Last Updated: July 6, 2023

By: Rob Walchack, PharmD, BCOP

About this PQI

This PQI will discuss the use of oral avapritinib in patients with indolent systemic mastocytosis (ISM).

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care. Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Find a PQI